{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:10:10Z","timestamp":1784232610071,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1604,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.rmed.2008.11.003","type":"journal-article","created":{"date-parts":[[2009,1,10]],"date-time":"2009-01-10T06:11:02Z","timestamp":1231567862000},"page":"542-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis"],"prefix":"10.1016","volume":"103","author":[{"given":"Tjard","family":"Schermer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Chavannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dekhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Muris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier","family":"Akkermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno","family":"van Schayck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"van Weel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmed.2008.11.003_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/ajrccm.164.4.2003167","article-title":"The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands","volume":"164","author":"Feenstra","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2008.11.003_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rmed.2008.11.003_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1183\/09031936.04.00016804","article-title":"Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease","volume":"23","author":"Dekhuijzen","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2008.11.003_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review","volume":"16","author":"Stey","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2008.11.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.322.7297.1271","article-title":"Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review","volume":"322","author":"Poole","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.rmed.2008.11.003_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic broncho-pulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clin Ther"},{"issue":"9470","key":"10.1016\/j.rmed.2008.11.003_bib7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2008.11.003_bib8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1164\/rccm.2105025","article-title":"The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study","volume":"165","author":"Hattotuwa","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.rmed.2008.11.003_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-138-12-200306170-00008","article-title":"Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis","volume":"138","author":"Highland","year":"2003","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.rmed.2008.11.003_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thorax.58.11.937","article-title":"Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis","volume":"58","author":"Sutherland","year":"2003","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2008.11.003_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(02)01143-9","article-title":"The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials","volume":"113","author":"Alsaeedi","year":"2002","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.rmed.2008.11.003_bib12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European respiratory society task force","volume":"8","author":"Siafakas","year":"1995","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.rmed.2008.11.003_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life for clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2008.11.003_bib14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind placebo controlled study of fluticasone propionate in patiens with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2008.11.003_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.93.05080945","article-title":"Inhaled beclomethasone improves the course of asthma and COPD","volume":"5","author":"Dompeling","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2008.11.003_bib16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1378\/chest.109.5.1156","article-title":"Effects of long-term treatment with corticosteroids in COPD","volume":"109","author":"Renkema","year":"1996","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2008.11.003_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/thx.54.11.995","article-title":"An empirical comparison of the St George's respiratory questionnaire (SGRQ) and the chronic respiratory disease questionnaire (CRQ) in a clinical trial setting","volume":"54","author":"Rutten-van Molken","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2008.11.003_bib18","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2008.11.003_bib19","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(98)10019-3","article-title":"Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial","volume":"353","author":"Vestbo","year":"1999","journal-title":"Lancet"},{"issue":"s","key":"10.1016\/j.rmed.2008.11.003_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the european respiratory society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"issue":"5","key":"10.1016\/j.rmed.2008.11.003_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0954-6111(97)90034-2","article-title":"The development of the \u2018Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)\u2019: a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease","volume":"91","author":"Maille","year":"1997","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.rmed.2008.11.003_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.200508-1338PP","article-title":"Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease","volume":"173","author":"Suissa","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rmed.2008.11.003_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thx.2007.082636","article-title":"Counting, analyzing and reporting exacerbations of COPD in randomized, controlled trials","volume":"63","author":"Aaron","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2008.11.003_bib24","unstructured":"Global initiative for chronic obstructive lung disease (GOLD). <www.goldcopd.com>; 2006 [accessed 17.09.07]. Unpublished work."},{"key":"10.1016\/j.rmed.2008.11.003_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pcrj.2003.11.005","article-title":"Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice","volume":"13","author":"Schermer","year":"2004","journal-title":"Prim Care Respir J"},{"issue":"8","key":"10.1016\/j.rmed.2008.11.003_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/thorax.58.8.659","article-title":"Bronchodilator reversibility testing in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.rmed.2008.11.003_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/thorax.58.11.911","article-title":"So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all?","volume":"58","author":"Burge","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2008.11.003_bib28","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200012283432601","article-title":"Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease","volume":"343","author":"Wise","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.rmed.2008.11.003_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2008.11.003_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/thx.52.1.67","article-title":"Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease","volume":"52","author":"Osman","year":"1997","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2008.11.003_bib31","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1378\/chest.124.4.1421","article-title":"A comparison of the original chronic respiratory questionnaire with a standardized version","volume":"124","author":"Schunemann","year":"2003","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2008.11.003_bib32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","article-title":"Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study","volume":"166","author":"van der Valk","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rmed.2008.11.003_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1183\/09031936.03.00083703","article-title":"One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease","volume":"23","author":"Oostenbrink","year":"2004","journal-title":"Eur Respir J"},{"issue":"9356","key":"10.1016\/j.rmed.2008.11.003_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2008.11.003_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/ajrccm.164.3.2002052","article-title":"Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction","volume":"164","author":"O'Brien","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rmed.2008.11.003_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/thx.2004.034280","article-title":"Withdrawal of fluticasone propionate from combined salmeterol\/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial","volume":"60","author":"Wouters","year":"2005","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2008.11.003_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0954-6111(99)90001-X","article-title":"An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease","volume":"93","author":"Jarad","year":"1999","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2008.11.003_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rmed.2005.04.004","article-title":"Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice","volume":"100","author":"Hoogendoorn","year":"2006","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2008.11.003_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611108003946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611108003946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:53:10Z","timestamp":1760611990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611108003946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0954611108003946"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2008.11.003","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2008.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}